HepatoSys, Lonza collaborate on liver cell research
Two North Carolina bioscience companies with expertise in human liver cells are joining forces to improve the quantity and quality of those cells for use in pharmaceutical research and drug testing. Charlotte-based HepatoSys has received a $366,000 Phase I grant from the federal Small Business Innovation Research (SBIR) program to fund the research. It will team up with Lonza which acquired Triangle Research Labs of Research Triangle Park in June 2016 to explore HepatoSys’ patented technology for rejuvenating donated human livers that aren’t healthy enough for organ transplants. Pharmaceutical companies spend about $1.5 billion a year on drug testing using human liver cells, called hepatocytes,...
Read More
